Alcohol and cancer: going deeper than the headline
The headline position is already covered in this series: the International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen — the highest category — meaning the evidence for a causal relationship between alcohol consumption and cancer is considered sufficient at the population level. That post covered the IARC position, the dose-response relationship, and the seven cancer types most strongly linked to alcohol exposure.
This post goes deeper. It looks at the biological mechanisms through which alcohol causes cancer, the question of whether any level of consumption is truly “safe,” the specific risk profile for women, and what the evidence says about risk modification after stopping or reducing drinking.
How alcohol causes cancer: the mechanisms
Alcohol does not cause cancer by a single pathway. Several converging mechanisms have been identified, each with different tissue-specific implications.
Acetaldehyde. When alcohol is metabolised by the body, the first breakdown product is acetaldehyde — a highly reactive compound that directly damages DNA. Acetaldehyde forms adducts with DNA strands, interfering with replication and repair. It is classified as a probable carcinogen in its own right by the IARC, and is considered the primary mechanism behind alcohol’s carcinogenicity in the upper gastrointestinal tract, including the mouth, throat, oesophagus, and liver. Genetic variants in alcohol metabolism enzymes (particularly ALDH2, which clears acetaldehyde) affect individual susceptibility — people with slower acetaldehyde clearance face higher cancer risk from the same alcohol exposure.
Oestrogen elevation. Alcohol consumption raises circulating oestrogen levels in women. The mechanism is multifactorial: alcohol inhibits hepatic oestrogen clearance, may stimulate ovarian oestrogen production, and influences aromatase activity in peripheral tissues. Even moderate alcohol consumption — one drink per day — has been associated with measurable increases in circulating oestradiol. This is the primary proposed mechanism for alcohol’s contribution to breast cancer risk, where oestrogen is a well-established driver of tumour growth in hormone-receptor-positive subtypes.
Reactive oxygen species and oxidative stress. Alcohol metabolism generates reactive oxygen species (ROS) — unstable molecules that damage DNA, proteins, and lipid membranes. Chronic alcohol consumption depletes cellular antioxidant defences, including glutathione, creating a state of sustained oxidative stress. This is particularly relevant in the liver, where the metabolic burden of alcohol processing is highest, and contributes to the stepwise progression from alcoholic liver disease to cirrhosis to hepatocellular carcinoma.
Folate depletion. Alcohol interferes with the absorption, metabolism, and utilisation of folate — the B-vitamin central to one-carbon metabolism and DNA methylation. Folate deficiency impairs the body’s capacity to synthesise and repair DNA correctly, and is associated with dysregulated DNA methylation patterns. This mechanism is most relevant to colorectal cancer risk, where folate status is one of the more consistent nutritional predictors.
Intestinal permeability and microbiome disruption. Chronic alcohol consumption increases intestinal permeability — the state in which bacterial endotoxins cross the gut barrier into systemic circulation, driving low-grade systemic inflammation. This contributes to the hepatic inflammation that underpins alcoholic liver disease, and may contribute more broadly to the pro-inflammatory environment associated with cancer risk.
Is there a safe level?
This remains one of the most contested questions in nutritional epidemiology. For many years, observational studies suggested that low to moderate alcohol consumption was associated with reduced cardiovascular risk — the so-called “J-shaped curve.” This finding contributed to the cultural normalisation of moderate drinking as benign or even beneficial.
The J-shaped curve has been substantially challenged by more recent analyses. A 2018 Lancet paper — the Global Burden of Disease 2016 Alcohol Collaborators study — analysed data from 195 countries and concluded that the safest level of alcohol consumption for overall health is zero. The cardiovascular benefit of low alcohol consumption, when present, was found to be offset by increased cancer risk, such that no net health benefit could be demonstrated at any consumption level when all outcomes were considered together.
A 2022 review published in Nutrients synthesising the evidence on alcohol and chronic disease, including the IARC carcinogen classification, similarly concluded that there is no established safe threshold for alcohol’s carcinogenic effects. The dose-response relationship for several alcohol-associated cancers — including breast, oral, and oesophageal — appears to extend down to low levels of consumption, without a clear floor below which risk is absent.
This does not mean that one drink per week carries the same absolute risk as heavy daily drinking. Absolute risk at low consumption levels remains small. But the relative risk is non-zero, and the threshold below which cancer risk is eliminated has not been established.
Women and alcohol: a specific risk profile
Women metabolise alcohol differently from men. Body composition, lower gastric alcohol dehydrogenase activity, and hormonal factors mean that women achieve higher blood alcohol concentrations from the same dose relative to body weight, and face greater tissue exposure per unit consumed.
The breast cancer risk associated with alcohol is particularly well characterised. Meta-analyses consistently find that each additional drink per day is associated with a 7–10% increase in relative breast cancer risk. For a woman at average population risk, this translates into a modest absolute risk increase — but for women with elevated baseline risk (family history, BRCA status, dense breast tissue, high endogenous oestrogen), the addition of alcohol to the risk profile is more consequential.
The oestrogen-elevation mechanism is directly relevant to perimenopausal and postmenopausal women. In this population, where oestrogen levels are already in flux and where hormone-receptor-positive breast cancer incidence rises steeply, the oestrogen-elevating effect of even moderate alcohol consumption represents a biologically plausible additional risk.
Risk modification: does reducing or stopping drinking help?
The carcinogenic effects of alcohol are not irreversible. Observational evidence consistently finds that people who stop drinking have lower cancer risk than those who continue, and that risk declines over time after cessation — though it does not always return to the level of never-drinkers, particularly for cancers where cumulative exposure plays a role.
For breast cancer specifically, studies suggest that the excess risk associated with alcohol consumption begins to decline within years of stopping, and that the risk in former drinkers approaches that of never-drinkers over a period of roughly ten years.
This is consistent with the mechanistic picture: the DNA-damaging effects of acetaldehyde and oxidative stress are ongoing processes that depend on continued exposure. Remove the exposure and the rate of DNA damage returns towards baseline. The folate depletion and oestrogen elevation effects similarly normalise after cessation.
What this means in practice
The evidence does not support the idea that moderate alcohol consumption is a benign habit for women who are concerned about cancer risk. The mechanisms are real, the dose-response extends to low consumption levels, and the oestrogen-elevation pathway is specifically relevant to the perimenopausal and postmenopausal population.
Reducing consumption is worthwhile at any level. Moving from seven drinks per week to three is meaningful. Moving from three to zero removes the exposure entirely.
If you drink, folate status is worth protecting. Ensuring adequate dietary folate — from leafy greens, legumes, and whole grains — and considering a methylfolate supplement if folate intake is uncertain, partially offsets one of the biological pathways through which alcohol increases cancer risk.
The social and psychological dimensions of alcohol are real and should not be dismissed. But they are separate from the biological risk question, and the evidence on that question is now sufficiently clear that it warrants honest, direct communication rather than reassuring hedging.
The bottom line
Alcohol causes cancer through multiple converging mechanisms — acetaldehyde-mediated DNA damage, oestrogen elevation, oxidative stress, folate depletion, and gut barrier disruption. The dose-response relationship extends to low levels of consumption, and no safe threshold has been established. For women, the oestrogen-elevation pathway creates a specific risk for hormone-receptor-positive breast cancer that is directly relevant to the perimenopausal decade. Reducing or eliminating alcohol consumption reduces ongoing cancer risk, and the excess risk associated with past consumption declines meaningfully after cessation.
Scientific references
- GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–1035. PMID: 30146330. DOI: 10.1016/S0140-6736(18)31310-2
- Griswold MG, et al. Alcohol and chronic disease: synthesis of the evidence including IARC carcinogen classification. Nutrients. 2022. DOI: 10.3390/nu14091954
- Patel AV, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2020;70(4):245–271. DOI: 10.3322/caac.21591
This article is written for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, prevent, or cure any medical condition, including cancer. If you have a cancer diagnosis or are undergoing treatment, please discuss any lifestyle or dietary changes with your oncologist or medical team before making them. The studies cited reflect current research at the time of writing; the field is evolving rapidly and findings may be updated or superseded. Chloe Archard is a nutritional health coach, not a medical doctor.
